🇺🇸 FDA
Patent

US 8951794

Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory

granted A61KA61K38/00A61K38/08

Quick answer

US patent 8951794 (Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory) held by The Regents of the University of California expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/10, A61K38/1709